Liang Yunlong
University of Essex, Colchester, UK.
BMJ Public Health. 2024 Mar 22;2(1):e000564. doi: 10.1136/bmjph-2023-000564. eCollection 2024 Jun.
Health conditions of participants can significantly affect longitudinal drop-out in population-based epidemiological surveys, yet few studies have examined the association between chronic pain (CP) and follow-up attrition.
The Midlife in the United States study (MIDUS) was used to explore the longitudinal association between CP and survey attrition. CP was assessed by three measures: the presence of CP, CP interference and the number of pain sites at MIDUS 2. The types of sample attrition at MIDUS 3 encompassed several categories: complete, refusal to participate, inability to participate due to physical or mental constraints, deceased, non-working numbers, participants consistently unavailable for interviews, global refusal or withdrew from the study and not fielded. Multinomial logistic regression was employed to examine these relationships and to explore the moderation effects of sociodemographic variables and multiple chronic conditions on these associations.
High-interference pain was associated with a 162% increased risk (RR 2.62, 95% CI 1.12 to 6.16, p=0.026) of being physically and mentally unable to participate in MIDUS 3. Individuals reporting the presence of CP (RR 0.65, 95% CI 0.45 to 0.95, p=0.028) and those with three or more CP sites (RR 0.48, 95% CI 0.27 to 0.87, p=0.016) were less likely to refuse participation in MIDUS 3. However, no further significant associations or moderating effects were identified.
Population-based epidemiological surveys may be susceptible to attrition bias from participants with CP, necessitating the adoption of adaptive survey methodologies.
在基于人群的流行病学调查中,参与者的健康状况会显著影响纵向失访情况,但很少有研究探讨慢性疼痛(CP)与随访损耗之间的关联。
利用美国中年研究(MIDUS)来探究CP与调查损耗之间的纵向关联。通过三种测量方法评估CP:CP的存在情况、CP干扰以及在MIDUS 2时的疼痛部位数量。MIDUS 3时的样本损耗类型包括几类:完整、拒绝参与、因身体或精神限制无法参与、死亡、无效电话号码、参与者始终无法接受访谈、全面拒绝或退出研究以及未进行调查。采用多项逻辑回归来检验这些关系,并探讨社会人口学变量和多种慢性病对这些关联的调节作用。
高干扰性疼痛与身心无法参与MIDUS 3的风险增加162%(风险比2.62,95%置信区间1.12至6.16,p = 0.026)相关。报告存在CP的个体(风险比0.65,95%置信区间0.45至0.95,p = 0.028)以及有三个或更多CP部位的个体(风险比0.48,95%置信区间0.27至0.87,p = 0.016)拒绝参与MIDUS 3的可能性较小。然而,未发现进一步的显著关联或调节作用。
基于人群的流行病学调查可能容易受到CP患者损耗偏差的影响,因此需要采用适应性调查方法。